English
简体中文
Total: £ 56.28
Published Date: 2025-06-13 | Pages: 131 | Tables: 137 | Medical Care
In 2024, the global market size of Transcatheter Aortic Valve Replacement (TAVR) was estimated to be worth US$ 8771 million and is forecast to reach approximately US$ 17790 million by 2031 with a CAGR of 10.8% during the forecast period 2025-2031.
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
The Transcatheter Aortic Valve Replacement (TAVR) market is primarily driven by the increasing prevalence of aortic stenosis and the growing aging population worldwide. As people live longer, the incidence of age-related cardiovascular conditions, such as aortic valve disease, is on the rise. TAVR offers a minimally invasive alternative to traditional open-heart surgery, making it a highly attractive option for elderly patients or those with high surgical risk. Additionally, technological advancements in TAVR devices, such as improved valve designs, delivery systems, and procedural techniques, have contributed to enhanced patient outcomes and safety, further expanding the market. The increasing acceptance of TAVR as a first-line treatment, even for intermediate-risk patients, also fuels market growth.
However, the TAVR market faces several challenges, primarily the high cost of the procedure and devices. Despite its advantages, TAVR is still a relatively expensive treatment, which can limit its accessibility, particularly in low- and middle-income countries or healthcare systems with constrained budgets. Furthermore, the long-term durability of TAVR valves remains a concern for both physicians and patients, as the procedure is relatively new compared to traditional surgical valve replacements. Ongoing research and clinical trials are needed to better understand the long-term outcomes of TAVR, which could influence its adoption and cost-effectiveness in the future.
Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, etc. are the leaders of the industry, Top 5 compnay market share are about 90%
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transcatheter Aortic Valve Replacement (TAVR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcatheter Aortic Valve Replacement (TAVR).
The Transcatheter Aortic Valve Replacement (TAVR) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transcatheter Aortic Valve Replacement (TAVR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcatheter Aortic Valve Replacement (TAVR) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
Venus Medtech
Bracco (HLT)
JenaValve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
MicroPort
Segment by Type
Transfemoral Approach
Transapical Approach
Others
Segment by Application
Aortic Stenosis
Aortic Regurgitation
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Transcatheter Aortic Valve Replacement (TAVR) in global and regional level.
Chapter 3: Detailed analysis of Transcatheter Aortic Valve Replacement (TAVR) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transcatheter Aortic Valve Replacement (TAVR) revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Transcatheter Aortic Valve Replacement (TAVR) Product Introduction
1.2 Market by Type
1.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Transfemoral Approach
1.2.3 Transapical Approach
1.2.4 Others
1.3 Market by Application
1.3.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Aortic Stenosis
1.3.3 Aortic Regurgitation
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Estimates and Forecasts
2.2 Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region: 2024 Versus 2031
2.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Region: 2020-2025
2.2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Forecast by Region (2026-2031)
2.2.3 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2020-2031)
3.1.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2020-2031)
3.2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Transfemoral Approach of Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application
3.3.2 Transapical Approach of Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application
3.3.3 Others of Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application
4 Global Transcatheter Aortic Valve Replacement (TAVR) by Company
4.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2020-2025)
4.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Transcatheter Aortic Valve Replacement (TAVR) Companies around the World: Ranking by Revenue
4.3.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Transcatheter Aortic Valve Replacement (TAVR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Transcatheter Aortic Valve Replacement (TAVR) Companies Headquarters & Product Type
4.4.1 Global Transcatheter Aortic Valve Replacement (TAVR) Companies Headquarters
4.4.2 Date of International Companies Enter into Transcatheter Aortic Valve Replacement (TAVR) Market
4.4.3 Global Transcatheter Aortic Valve Replacement (TAVR) Companies Product & Service
4.4.4 Transfemoral Approach Revenue Market Share of Transcatheter Aortic Valve Replacement (TAVR) by Company
4.4.5 Transapical Approach Revenue Market Share of Transcatheter Aortic Valve Replacement (TAVR) by Company
4.4.6 Others Revenue Market Share of Transcatheter Aortic Valve Replacement (TAVR) by Company
4.5 Global Transcatheter Aortic Valve Replacement (TAVR) Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Edwards Lifesciences
5.1.1 Edwards Lifesciences Corporation Information
5.1.2 Edwards Lifesciences Description, Business Overview
5.1.3 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Products Offered
5.1.4 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2020-2025)
5.1.5 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2024
5.1.6 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2024
5.1.7 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2024
5.1.8 Edwards Lifesciences Recent Developments
5.2 Medtronic
5.2.1 Medtronic Corporation Information
5.2.2 Medtronic Description, Business Overview
5.2.3 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Products Offered
5.2.4 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2020-2025)
5.2.5 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2024
5.2.6 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2024
5.2.7 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2024
5.2.8 Medtronic Recent Developments
5.3 Abbott
5.3.1 Abbott Corporation Information
5.3.2 Abbott Description, Business Overview
5.3.3 Abbott Transcatheter Aortic Valve Replacement (TAVR) Products Offered
5.3.4 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2020-2025)
5.3.5 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2024
5.3.6 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2024
5.3.7 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2024
5.3.8 Abbott Recent Developments
5.4 Boston Scientific
5.4.1 Boston Scientific Corporation Information
5.4.2 Boston Scientific Description, Business Overview
5.4.3 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Products Offered
5.4.4 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2020-2025)
5.4.5 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2024
5.4.6 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2024
5.4.7 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2024
5.4.8 Boston Scientific Recent Developments
5.5 Meril Life Sciences
5.5.1 Meril Life Sciences Corporation Information
5.5.2 Meril Life Sciences Description, Business Overview
5.5.3 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Products Offered
5.5.4 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2020-2025)
5.5.5 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2024
5.5.6 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2024
5.5.7 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2024
5.5.8 Meril Life Sciences Recent Developments
5.6 Venus Medtech
5.6.1 Venus Medtech Corporation Information
5.6.2 Venus Medtech Description, Business Overview
5.6.3 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Products Offered
5.6.4 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2020-2025)
5.6.5 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2024
5.6.6 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2024
5.6.7 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2024
5.6.8 Venus Medtech Recent Developments
5.7 Bracco (HLT)
5.7.1 Bracco (HLT) Corporation Information
5.7.2 Bracco (HLT) Description, Business Overview
5.7.3 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Products Offered
5.7.4 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2020-2025)
5.7.5 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2024
5.7.6 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2024
5.7.7 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2024
5.7.8 Bracco (HLT) Recent Developments
5.8 JenaValve Technology
5.8.1 JenaValve Technology Corporation Information
5.8.2 JenaValve Technology Description, Business Overview
5.8.3 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Products Offered
5.8.4 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2020-2025)
5.8.5 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2024
5.8.6 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2024
5.8.7 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2024
5.8.8 JenaValve Technology Recent Developments
5.9 Suzhou Jiecheng Medical Technology Co.
5.9.1 Suzhou Jiecheng Medical Technology Co. Corporation Information
5.9.2 Suzhou Jiecheng Medical Technology Co. Description, Business Overview
5.9.3 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Products Offered
5.9.4 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2020-2025)
5.9.5 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2024
5.9.6 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2024
5.9.7 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2024
5.9.8 Suzhou Jiecheng Medical Technology Co. Recent Developments
5.10 Peijia Medical
5.10.1 Peijia Medical Corporation Information
5.10.2 Peijia Medical Description, Business Overview
5.10.3 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Products Offered
5.10.4 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2020-2025)
5.10.5 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2024
5.10.6 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2024
5.10.7 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2024
5.10.8 Peijia Medical Recent Developments
5.11 MicroPort
5.11.1 MicroPort Corporation Information
5.11.2 MicroPort Description, Business Overview
5.11.3 MicroPort Transcatheter Aortic Valve Replacement (TAVR) Products Offered
5.11.4 MicroPort Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2020-2025)
5.11.5 MicroPort Transcatheter Aortic Valve Replacement (TAVR) Revenue by Product in 2024
5.11.6 MicroPort Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application in 2024
5.11.7 MicroPort Transcatheter Aortic Valve Replacement (TAVR) Revenue by Geographic Area in 2024
5.11.8 MicroPort Recent Developments
6 North America
6.1 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size YoY Growth 2020-2031
6.2 North America Transcatheter Aortic Valve Replacement (TAVR) Market Facts & Figures by Country (2020-2031)
6.3 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2020-2025)
6.4 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2020-2025)
7.4 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2020-2025)
8 Europe
8.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size YoY Growth 2020-2031
8.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Facts & Figures by Country (2020-2031)
8.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2020-2025)
8.4 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Size YoY Growth 2020-2031
9.2 Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Facts & Figures by Country (2020-2031)
9.3 Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2020-2025)
9.4 Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2020-2025)
10.4 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Transcatheter Aortic Valve Replacement (TAVR) Supply Chain Analysis
11.2 Transcatheter Aortic Valve Replacement (TAVR) Key Raw Materials and Upstream Suppliers
11.3 Transcatheter Aortic Valve Replacement (TAVR) Clients Analysis
11.4 Transcatheter Aortic Valve Replacement (TAVR) Sales Channel and Sales Model Analysis
11.4.1 Transcatheter Aortic Valve Replacement (TAVR) Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Transcatheter Aortic Valve Replacement (TAVR) Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Transcatheter Aortic Valve Replacement (TAVR) Distributors
12 Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics
12.1 Transcatheter Aortic Valve Replacement (TAVR) Industry Trends
12.2 Transcatheter Aortic Valve Replacement (TAVR) Market Drivers
12.3 Transcatheter Aortic Valve Replacement (TAVR) Market Challenges
12.4 Transcatheter Aortic Valve Replacement (TAVR) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2020-2025) & (US$ Million)
Table 11. Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Transcatheter Aortic Valve Replacement (TAVR) Players by Revenue (US$ Million) in 2024
Table 13. Global Transcatheter Aortic Valve Replacement (TAVR) Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Transcatheter Aortic Valve Replacement (TAVR) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcatheter Aortic Valve Replacement (TAVR) as of 2024)
Table 15. Global Transcatheter Aortic Valve Replacement (TAVR) Companies Headquarters
Table 16. Date of International Companies Enter into Transcatheter Aortic Valve Replacement (TAVR) Market
Table 17. Global Transcatheter Aortic Valve Replacement (TAVR) Companies Product & Service
Table 18. Global Transcatheter Aortic Valve Replacement (TAVR) Mergers & Acquisitions, Expansion Plans
Table 19. Edwards Lifesciences Corporation Information
Table 20. Edwards Lifesciences Description and Business Overview
Table 21. Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Product
Table 22. Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Edwards Lifesciences Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2024
Table 24. Edwards Lifesciences Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2024
Table 25. Edwards Lifesciences Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2024
Table 26. Edwards Lifesciences Recent Developments
Table 27. Medtronic Corporation Information
Table 28. Medtronic Description and Business Overview
Table 29. Medtronic Transcatheter Aortic Valve Replacement (TAVR) Product
Table 30. Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Medtronic Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2024
Table 32. Medtronic Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2024
Table 33. Medtronic Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2024
Table 34. Medtronic Recent Developments
Table 35. Abbott Corporation Information
Table 36. Abbott Description and Business Overview
Table 37. Abbott Transcatheter Aortic Valve Replacement (TAVR) Product
Table 38. Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Abbott Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2024
Table 40. Abbott Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2024
Table 41. Abbott Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2024
Table 42. Abbott Recent Developments
Table 43. Boston Scientific Corporation Information
Table 44. Boston Scientific Description and Business Overview
Table 45. Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Product
Table 46. Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Boston Scientific Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2024
Table 48. Boston Scientific Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2024
Table 49. Boston Scientific Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2024
Table 50. Boston Scientific Recent Developments
Table 51. Meril Life Sciences Corporation Information
Table 52. Meril Life Sciences Description and Business Overview
Table 53. Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Product
Table 54. Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Meril Life Sciences Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2024
Table 56. Meril Life Sciences Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2024
Table 57. Meril Life Sciences Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2024
Table 58. Meril Life Sciences Recent Developments
Table 59. Venus Medtech Corporation Information
Table 60. Venus Medtech Description and Business Overview
Table 61. Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Product
Table 62. Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Venus Medtech Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2024
Table 64. Venus Medtech Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2024
Table 65. Venus Medtech Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2024
Table 66. Venus Medtech Recent Developments
Table 67. Bracco (HLT) Corporation Information
Table 68. Bracco (HLT) Description and Business Overview
Table 69. Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Product
Table 70. Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Bracco (HLT) Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2024
Table 72. Bracco (HLT) Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2024
Table 73. Bracco (HLT) Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2024
Table 74. Bracco (HLT) Recent Developments
Table 75. JenaValve Technology Corporation Information
Table 76. JenaValve Technology Description and Business Overview
Table 77. JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Product
Table 78. JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. JenaValve Technology Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2024
Table 80. JenaValve Technology Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2024
Table 81. JenaValve Technology Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2024
Table 82. JenaValve Technology Recent Developments
Table 83. Suzhou Jiecheng Medical Technology Co. Corporation Information
Table 84. Suzhou Jiecheng Medical Technology Co. Description and Business Overview
Table 85. Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Product
Table 86. Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Suzhou Jiecheng Medical Technology Co. Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2024
Table 88. Suzhou Jiecheng Medical Technology Co. Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2024
Table 89. Suzhou Jiecheng Medical Technology Co. Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2024
Table 90. Suzhou Jiecheng Medical Technology Co. Recent Developments
Table 91. Peijia Medical Corporation Information
Table 92. Peijia Medical Description and Business Overview
Table 93. Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Product
Table 94. Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Peijia Medical Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2024
Table 96. Peijia Medical Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2024
Table 97. Peijia Medical Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2024
Table 98. Peijia Medical Recent Developments
Table 99. MicroPort Corporation Information
Table 100. MicroPort Description and Business Overview
Table 101. MicroPort Transcatheter Aortic Valve Replacement (TAVR) Product
Table 102. MicroPort Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. MicroPort Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Product in 2024
Table 104. MicroPort Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Application in 2024
Table 105. MicroPort Revenue Proportion of Transcatheter Aortic Valve Replacement (TAVR) by Geographic Area in 2024
Table 106. MicroPort Recent Developments
Table 107. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2020-2025) & (US$ Million)
Table 108. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2026-2031) & (US$ Million)
Table 109. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2020-2025) & (US$ Million)
Table 110. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2020-2025) & (US$ Million)
Table 111. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Region (2020-2025) & (US$ Million)
Table 112. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Region (2026-2031) & (US$ Million)
Table 113. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2020-2025) & (US$ Million)
Table 114. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2020-2025) & (US$ Million)
Table 115. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2020-2025) & (US$ Million)
Table 116. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2026-2031) & (US$ Million)
Table 117. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2020-2025) & (US$ Million)
Table 118. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2020-2025) & (US$ Million)
Table 119. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2020-2025) & (US$ Million)
Table 120. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2026-2031) & (US$ Million)
Table 121. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2020-2025) & (US$ Million)
Table 122. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2020-2025) & (US$ Million)
Table 123. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2020-2025) & (US$ Million)
Table 124. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2026-2031) & (US$ Million)
Table 125. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2020-2025) & (US$ Million)
Table 126. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2020-2025) & (US$ Million)
Table 127. Transcatheter Aortic Valve Replacement (TAVR) Key Raw Materials, Industry Status and Trend
Table 128. Transcatheter Aortic Valve Replacement (TAVR) Key Raw Materials and Upstream Suppliers
Table 129. Transcatheter Aortic Valve Replacement (TAVR) Clients Status and Trend
Table 130. Transcatheter Aortic Valve Replacement (TAVR) Typical Clients
Table 131. Transcatheter Aortic Valve Replacement (TAVR) Distributors
Table 132. Transcatheter Aortic Valve Replacement (TAVR) Market Trends
Table 133. Transcatheter Aortic Valve Replacement (TAVR) Market Drivers
Table 134. Transcatheter Aortic Valve Replacement (TAVR) Market Challenges
Table 135. Transcatheter Aortic Valve Replacement (TAVR) Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Transcatheter Aortic Valve Replacement (TAVR) Product Picture
Figure 2. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type in 2024 & 2031
Figure 4. Transfemoral Approach Product Picture
Figure 5. Transapical Approach Product Picture
Figure 6. Others Product Picture
Figure 7. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application in 2024 & 2031
Figure 9. Aortic Stenosis
Figure 10. Aortic Regurgitation
Figure 11. Others
Figure 12. Transcatheter Aortic Valve Replacement (TAVR) Report Years Considered
Figure 13. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size (2020-2031) & (US$ Million)
Figure 15. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Region (2020-2031)
Figure 17. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Transfemoral Approach of Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application, 2024 VS 2031
Figure 20. Transapical Approach of Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application, 2024 VS 2031
Figure 21. Others of Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application, 2024 VS 2031
Figure 22. Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Company (2024)
Figure 23. Transcatheter Aortic Valve Replacement (TAVR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Transfemoral Approach Revenue Proportion by Company in 2024
Figure 25. Transapical Approach Revenue Proportion by Company in 2024
Figure 26. Others Revenue Proportion by Company in 2024
Figure 27. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue 2020-2031 (US$ Million)
Figure 28. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2020-2025)
Figure 29. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2020-2025)
Figure 30. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue 2020-2031 (US$ Million)
Figure 31. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Region (2020-2031)
Figure 32. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2020-2025)
Figure 33. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2020-2025)
Figure 34. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 35. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Country (2020-2031)
Figure 36. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2020-2025)
Figure 37. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2020-2025)
Figure 38. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Country (2020-2031)
Figure 40. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2020-2025)
Figure 41. Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2020-2025)
Figure 42. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Country (2020-2031)
Figure 44. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2020-2025)
Figure 45. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2020-2025)
Figure 46. Transcatheter Aortic Valve Replacement (TAVR) Supply Chain (Upstream and Downstream Market)
Figure 47. Global Production Market Share of Transcatheter Aortic Valve Replacement (TAVR) Raw Materials by Region in 2024
Figure 48. Transcatheter Aortic Valve Replacement (TAVR) Distribution Channels
Figure 49. Global Transcatheter Aortic Valve Replacement (TAVR) Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 50. Global Transcatheter Aortic Valve Replacement (TAVR) Percentage 2020-2031: Online Sales VS Offline Sales
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
